Kiniksa Pharmaceuticals International, PLC

KNSA·NASDAQ·$52.86Share Price as of 11/2·$4BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/27/26 10-QQ2 ended 06/30/2607/28/26 10-QQ1 ended 03/31/2604/28/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2510/28/25

Disclosures

8-KCurrent report10/27/26 8-KCurrent report10/22/26 8-KCurrent report07/28/26 8-KCurrent report05/29/26 8-KCurrent report05/26/26

Prospectuses and Registrations

S-8Registration of securities for employees02/24/26 S-8Registration of securities for employees02/25/25 POS AMPost-effective amendment06/28/24 POS AMPost-effective amendment06/28/24 S-3Shelf registration06/28/24

Proxies

DEF 14ADefinitive proxy04/16/26 DEFA14AAdditional proxy materials04/16/26 DEFA14AAdditional proxy materials05/28/25 DEFA14AAdditional proxy materials05/09/25 DEF 14ADefinitive proxy04/21/25

Ownership

144Proposed sale of securities10/30/26 144Proposed sale of securities10/30/26 144Proposed sale of securities10/30/26 144Proposed sale of securities10/30/26 144Proposed sale of securities09/03/26

Other

ARSAnnual report to shareholders04/16/26 ARSAnnual report to shareholders04/21/25 15-15D/A15-15D/A07/23/24 EFFECTRequest for effectiveness07/03/24 EFFECTRequest for effectiveness07/03/24